EN DE

PT Citra Borneo Utama Tbk (CBUT) Fair Value & Analysis

Consumer Defensive · ID · Market cap 2.5T IDR

PC PT Citra Borneo Utama Tbk CBUT · JK
Price840.00 IDR
Fair Value713.50 IDR
Upside-15.1%
Quality49/100
Watch PT Citra Borneo Utama Tbk for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 0.8% net margin
Low debt · generates free cash flow
Trails peers (5/13)
Narrow moat 38/100
Evidence: High Range 535.12 IDR – 891.87 IDR Share as image

Fair value as of: Jul 11, 2026

From 22 valuation models · updated 30 days ago

Fair value updated Jul 11, 2026, revised from 1,043 IDR to 713.50 IDR (−31.6%) since Jun 24, 2026. Share price +7.0% over the past month.

Below-average quality, and screening another 15% overvalued on our models.

What matters now

  • Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder.
  • Our model range runs from 535.12 IDR (bear) to 891.87 IDR (bull), base 713.50 IDR. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 49/100 (below-average quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (4 years)

3,850 IDR 450.00 IDR Fair Value 713.50 IDR Nov 2022 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 11, 2026.

How to read this chart

45‑month range 450.00 IDR – 3,850 IDR · fair‑value band 535.12 IDR – 891.87 IDR · the 840.00 IDR price screens above the 713.50 IDR fair value. Dashed = 300-day average. As of Jul 11, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

PT Citra Borneo Utama Tbk (CBUT) currently trades at 840.00 IDR, while our model-based Fair Value estimate is 713.50 IDR, implying the stock looks roughly 15.1% overvalued today. The Quality Score stands at 49/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, PT Citra Borneo Utama Tbk generated revenue of 14.0T IDR at a net margin of 0.8%. Revenue declined 0.5% year over year. It earns a return on equity of 10.1%. Net debt stands at 1.8T IDR. Fundamentals as of Jul 11, 2026

Our scenario range runs from 535.12 IDR (bear case) to 891.87 IDR (bull case); at 840.00 IDR, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 63% below its 52-week high and 100% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at -15%, CBUT screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 519.03 IDR 1,171 IDR 2,452 IDR 80
Residual Income 313.66 IDR 348.46 IDR 578.93 IDR 76
ROIC Compounder 1,302 IDR 1,954 IDR 2,888 IDR 72
All 22 models by family
DCF Models
FCF DCF 544.08 IDR 1,026 IDR 2,407 IDR 38
5Y Revenue Exit 952.18 IDR 2,028 IDR 3,990 IDR 39
5Y EBITDA Exit 1,056 IDR 2,255 IDR 4,294 IDR 41
5Y P/E Exit 466.75 IDR 1,027 IDR 1,736 IDR 38
10Y Revenue Exit 788.56 IDR 1,968 IDR 3,604 IDR 36
10Y EBITDA Exit 910.55 IDR 2,164 IDR 4,475 IDR 37
10Y P/E Exit 488.83 IDR 1,050 IDR 1,988 IDR 35
Earnings-Based
Graham-Dodd 231.04 IDR 1,559 IDR 2,185 IDR 54
Lynch FV 457.11 IDR 653.02 IDR 848.92 IDR 50
PEG = 1.0 457.11 IDR 653.02 IDR 848.92 IDR 46
EPV 1,026 IDR 1,223 IDR 1,397 IDR 59
Multiples
P/E Multiple 535.12 IDR 713.50 IDR 891.87 IDR 63
P/S Multiple 433.19 IDR 577.59 IDR 721.99 IDR 58
P/B Multiple 433.19 IDR 577.59 IDR 721.99 IDR 55
EV/EBIT 1,505 IDR 2,035 IDR 2,565 IDR 53
EV/EBITDA 1,276 IDR 1,730 IDR 2,184 IDR 54
EV/Revenue 1,049 IDR 1,536 IDR 2,023 IDR 43
Asset-Based
NCAV (Graham) 177.70 IDR 238.12 IDR 355.40 IDR 50
Growth DCF
Growth DCF 519.03 IDR 1,171 IDR 2,452 IDR 80
Economic Profit
Residual Income 313.66 IDR 348.46 IDR 578.93 IDR 76
ROIC Compounder 1,302 IDR 1,954 IDR 2,888 IDR 72
Growth Earnings
Growth-Adj P/E 633.12 IDR 904.46 IDR 1,176 IDR 68

Widest divergence: DCF Models (1,968 IDR) versus Asset-Based (238.12 IDR). Highest evidence: Growth DCF (80).

Notify me when CBUT reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 14.0T IDR
Revenue growth (YoY) -0.5%
Net margin 0.8%
Return on equity 10.1%
Free cash flow 121B IDR FY2025
P/E ratio 22.8
More key figures
Operating margin 2.7%
EPS (TTM) 35.48 IDR
EPS growth (YoY) +11.6%
Net debt 1.8T IDR FY2025

Figures from reported company fundamentals · as of Jul 11, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 49/100

Of which business quality 50 · Market factors (momentum, volatility) 27

Profitability 55
Margins and returns on capital today
Quality Growth 78
Are margins and returns improving?
Cashflow 36
Earnings quality: real cash, not paper profit
Fin. Strength 37
Balance sheet, leverage, solvency risk
Investment 60
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 22
Price trend over the last 3–12 months (market factor)
52W Momentum 11
Distance to the 52-week high (market factor)
Net Issuance 48
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

PT Citra Borneo Utama Tbk engages in palm oil refining, and trading activities in Indonesia and internationally. The company offers product and services, such as refined bleached deodorized palm oil, refined bleached deodorized palm olein, refined bleached deodorized palm stearin, palm fatty acid distillate, crude palm kernel oil, and palm kernel expeller.

Full company description

PT Citra Borneo Utama Tbk engages in palm oil refining, and trading activities in Indonesia and internationally. The company offers product and services, such as refined bleached deodorized palm oil, refined bleached deodorized palm olein, refined bleached deodorized palm stearin, palm fatty acid distillate, crude palm kernel oil, and palm kernel expeller. The company was founded in 2013 and is headquartered in Pangkalan Bun, Indonesia. PT Citra Borneo Utama Tbk operates as a subsidiary of PT Citra Borneo Indah.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

PT Citra Borneo Utama Tbk reported revenue of 14.0T IDR in FY2025 versus 8.7T IDR in FY2021, a compound +12.7%/yr. Reported net income was 106B IDR in FY2025, compounding −21.9%/yr from FY2021.

Growth Quality 85/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
14.0T IDR
Latest YoY
+43.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.2%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+26.3%
Avg. growth/yr (6Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+27.2%
Revenue +12.7%/yr
FY21 8.7T IDR
FY22 9.6T IDR
FY23 10.3T IDR
FY24 9.8T IDR
FY25 14.0T IDR
Net income −21.9%/yr
FY21 286B IDR
FY22 223B IDR
FY23 144B IDR
FY24 68.2B IDR
FY25 106B IDR

CBUT screens 15% overvalued. Compare with Nestlé India Limited →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "PT Citra Borneo Utama Tbk Fair Value". https://www.fairvalue-calculator.com/stock/CBUT

Peer Group

Packaged Foods · 649 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 49 · Below median
Fair Value upside −15% · Below median
Return on equity (TTM) 10% · Above median
Return on assets 6% · Above median
Net margin (TTM) 1% · Below median
Operating margin (TTM) 3% · Below median
Revenue growth -1% · Below median
Debt / equity 0.50× · Higher than 75% of peers

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/E (TTM) 22.8× · Pricier than median
P/B 2.28× · Pricier than median
P/S (TTM) 0.18× · Cheaper than 75% of peers
P/FCF 0.0× · Cheaper than 75% of peers
EV/EBITDA 6.6× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 13 · sector 28
FUTURE 0 · sector 20
PAST 40 · sector 27
HEALTH 75 · sector 96
DIVIDEND 0 · sector 47

Insider activity: 30/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,427 ₹362.37 -75%
Britannia Industries Limited BRITANNIA ₹5,413 ₹1,870 -65%
Tata Consumer Products Limited TATACONSUM ₹1,089 ₹327.27 -70%
PT Indofood CBP Sukses Makmur Tbk ICBP 6,650 IDR 15,757 IDR +137%
Samyang Foods Co 003230 1,139,000 KRW 1,010,543 KRW -11%
Patanjali Foods Limited PATANJALI ₹413.80 ₹157.04 -62%
Vietnam Dairy Products Joint Stock Company VNM 58,500 VND 68,259 VND +17%
PT Mayora Indah Tbk, MYOR 1,750 IDR 2,699 IDR +54%
PT Cisarua Mountain Dairy Tbk CMRY 4,490 IDR 4,355 IDR -3%
Nongshim Co 004370 348,500 KRW 530,619 KRW +52%

Compare PT Citra Borneo Utama Tbk with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is PT Citra Borneo Utama Tbk (CBUT) overvalued or undervalued?
As of Jul 11, 2026, our model estimates a fair value of 713.50 IDR versus a price of 840.00 IDR, about −15% (overvalued).
What is the fair value of CBUT?
Our model-based fair value for PT Citra Borneo Utama Tbk is 713.50 IDR (as of Jul 11, 2026), built from audited fundamentals. The current price is 840.00 IDR.
What is the quality score of CBUT?
PT Citra Borneo Utama Tbk has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of PT Citra Borneo Utama Tbk (CBUT)?
PT Citra Borneo Utama Tbk reported trailing-twelve-month revenue of about 14.0T IDR (latest available figure, as of Jul 11, 2026).
What is the net profit margin of CBUT?
The net profit margin of PT Citra Borneo Utama Tbk is about 0.8%, meaning it keeps roughly 0.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track PT Citra Borneo Utama Tbk and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.